OCX - Oncocyte Corporation
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.08%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | |
|---|---|---|
| Fiscal Quarter | Q1 2025 | |
| Report Date | 05-12-2025 | |
| Cash flow financing | 28.558 M | |
| Other financing cash flows | 0.000 | |
| Cash flow | 22.393 M | |
| Net income | -6.671 M | |
| Depreciation | 484.000 K | |
| Changes in inventories | 49.000 K | |
| Changes in receivables | 0.000 | |
| Investing Cashflow | -307.000 K | |
| Net Borrowings | 0.000 | |
| Investing Activity Other | 0.000 | |
| Dividends Paid | 0.000 | |
| Exchange Rate Effect | 0.000 | |
| Capital Expenditures | 307.000 K | |
| Cash Change | 22.393 M |